Dogwood Therapeutics (DWTX) Institutional Ownership $5.38 -0.50 (-8.50%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$5.60 +0.23 (+4.18%) As of 02/21/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Dogwood Therapeutics (NASDAQ:DWTX)CurrentInstitutional OwnershipPercentage9.05%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$27.22KNumber ofInstitutional Sellers(last 12 months)0 Get DWTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Dogwood Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Dogwood Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025 Geode Capital Management LLC10,933$27K0.0%N/A0.822% (Data available from 1/1/2016 forward) DWTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DWTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Dogwood Therapeutics shares: Geode Capital Management LLC ($27K).Learn more on DWTX's institutional investors. What percentage of Dogwood Therapeutics stock is owned by institutional investors? 9.05% of Dogwood Therapeutics stock is owned by institutional investors. Learn more on DWTX's institutional investor holdings. Which institutional investors have been buying Dogwood Therapeutics stock? The following institutional investors have purchased Dogwood Therapeutics stock in the last 24 months: Geode Capital Management LLC ($10.93K). How much institutional buying is happening at Dogwood Therapeutics? Institutional investors have bought a total of 10,933 shares in the last 24 months. This purchase volume represents approximately $27.22K in transactions. Related Companies QTTB Major Shareholders BIVI Major Shareholders PLUR Major Shareholders SNYR Major Shareholders BFRG Major Shareholders IXHL Major Shareholders RLYB Major Shareholders PMN Major Shareholders CVM Major Shareholders MRNS Major Shareholders This page (NASDAQ:DWTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dogwood Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dogwood Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.